Eyewire News: The Podcast
Eyewire News: The Podcast

10.09.24

Aldeyra Resubmits NDA for DED Drug Reproxalap

Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and Bausch + Lomb launches a new digital e-commerce marketplace.

View full description +

MORE EPISODES

Show More